↓ Skip to main content

Sulpiride versus placebo for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, April 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter
12 tweeters

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Sulpiride versus placebo for schizophrenia
Published in
Cochrane database of systematic reviews, April 2009
DOI 10.1002/14651858.cd007811
Pubmed ID
Authors

Omori IM, Wang J, Omori, Ichiro M, Wang, Jijun

Abstract

Sulpiride is a relatively old antipsychotic drug reputed to have low incidence of adverse effects and an effect on the negative symptoms of schizophrenia. This relatively inexpensive antipsychotic drug has a similar neuropharmacological profile to several novel atypical drugs.

Twitter Demographics

The data shown below were collected from the profiles of 12 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
Unknown 29 97%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 6 20%
Student > Ph. D. Student 5 17%
Researcher 5 17%
Student > Postgraduate 3 10%
Student > Master 2 7%
Other 4 13%
Unknown 5 17%
Readers by discipline Count As %
Medicine and Dentistry 10 33%
Psychology 6 20%
Social Sciences 3 10%
Biochemistry, Genetics and Molecular Biology 2 7%
Decision Sciences 1 3%
Other 1 3%
Unknown 7 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 April 2014.
All research outputs
#2,537,997
of 14,002,013 outputs
Outputs from Cochrane database of systematic reviews
#5,368
of 10,793 outputs
Outputs of similar age
#28,494
of 152,794 outputs
Outputs of similar age from Cochrane database of systematic reviews
#48
of 122 outputs
Altmetric has tracked 14,002,013 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,793 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.4. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 152,794 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 122 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.